Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure

Conditions:   Cancer;   Covid-19 Interventions:   Biological: IMM-101;   Other: Observation Sponsors:   Canadian Cancer Trials Group;   Immodulon Therapeutics Ltd;   BioCan Rx;   Canadian Cancer Society Research Institute (CCSRI);   ATGen Canada Inc;   Canadian Centre for Applied Research in Cancer Control (ARCC) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials